Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
The sales reps’ claims about OxyContin’s safety were in many cases false — and partly led to Purdue pleading guilty to understating the risk of addiction.
No hay comentarios:
Publicar un comentario